Related Experiment Video
Updated: Jun 16, 2026

Operation Procedure and Precautions of Thread-Embedding Acupuncture Therapy in Alzheimer
Published on: May 10, 2024
[Alzheimer's disease]
1Department of Geriatric Medicine, Tokyo Medical University.
Abstract:
The insulin resistance and peripheral hyperinsulinemia have been known to promote the neurodegeneration in Alzheimer's disease (AD), such as beta amyloid (Abeta) deposits and increase of tau hyperphosphorylation. Therefore, correcting insulin dysregulation may offer a novel strategy for the treatment of AD. Pharmacologic treatment with thiazolidinedions, such as rosiglitazone and pioglitazone, agonists of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma), may offer some therapeutic relief of AD by lowering peripheral insulin and enhancing insulin sensitivity. In addition, PPARgamma agonists have been shown to inhibit inflammatory gene expression, alter Abeta homeostasis and exhibit neuroprotective effects. PPARgamma agonists represent a new and potentially efficacious treatment of AD.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual.
